If you're looking for more information on beta 138, you've come to the right place. Applied Technology Council recently released a new protocol known as ATC-138 Functional Recovery (Beta). You can read more about it here. The beta 138 mutation is a variant of hemoglobin. It is associated with mild anemia and has similar electrophoretic mobility. It also exhibits the same functional properties as Hb A.

Most beta globin gene mutations are point mutations in a functional region of the gene. Rarely, a mutation will result in a complete absence of beta globin chains. The following list of beta globin mutations is organized according to their severity and ethnic distribution. The list below contains more information on each mutation. The information is updated regularly. If you think you have beta 138, get tested today! You'll be glad you did!

The good news is that beta thalassemia patients have improved prognoses over the past twenty years, thanks to medical advances like iron chelation and transfusion therapy. However, cardiac disease remains the leading cause of death in patients with iron overload. This is one of the reasons why Beta138 levels in the blood are so high. Although the prognosis of beta thalassemia patients has improved, the outlook is not yet ideal.

Preventive measures for beta thalassemia include carrier identification, genetic counseling, and prenatal diagnosis. Earlier, carrier detection had been described and was the most effective way to prevent the disease. Through genetic counseling, at-risk individuals and couples are given information about the mode of inheritance and their risk of having a child affected with the disease. Prenatal diagnosis of beta 138 can be done by analyzing fetal cells. Usually, amniocentesis or chorionic villi sampling is performed at around 15 weeks gestation, while prenatal diagnosis requires identification of both disease-causing alleles.